Healthcare >> CEO Interviews >> May 29, 2000
WILLIAM G. GERBER, MD, has served as Chief Executive Officer of Epoch
Biosciences since September 1999. Prior to joining Epoch, Dr. Gerber
served as President and Chief Executive Officer of diaDexus LLC, a joint
venture established by Incyte Pharmaceuticals and SmithKline Beecham to
apply genomics to the discovery of novel diagnostic products. Dr. Gerber
previously served as Vice President and Chief Operating Officer of Onyx
Pharmaceuticals, a biotechnology firm involved in the discovery of novel
cancer therapeutics; as President of Chiron Diagnostics, and as Senior
Vice President and General Manager of the PCR Division with Cetus
Corporation. Dr. Gerber is a member of the Board of Directors of Sangamo
Biosciences, Inc. He also served on and was President of the Board of
Medical Quality Assurance in the State of California. He received his MD
and BS from the University of California, San Francisco Medical Center,
after attending Dartmouth College. Profile
company's history, activities and developments.
Dr. Gerber: Epoch is located in Redmond, Washington, near Seattle. We
have a
